Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 19, 2015 6:25 AM ET

Life Sciences Tools and Services

Company Overview of Complete Genomics, Inc.

Company Overview

Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company’s human genome sequencing services are used in various applications, including cancer research, Mendelian disease research, rare variant disease research, translational research, clinical trial optimization, and companion diagnostic discovery. It serves academic research centers, government research centers, bio...

2071 Stierlin Court

Mountain View, CA 94043

United States

Founded in 2005

255 Employees

Phone:

650-943-2800

Key Executives for Complete Genomics, Inc.

Co-Founder, Chairman, Chief Executive Officer and President
Age: 55
Co-Founder and Chief Scientific Officer
Age: 56
Co-Founder and Vice President of Financial Operations
Age: 71
Vice President of Operations
Age: 64
Senior Vice President, General Counsel and Secretary
Compensation as of Fiscal Year 2014.

Complete Genomics, Inc. Key Developments

Complete Genomics, Inc. Announces Highly-Accurate Whole Genome Sequencing Technology

Complete Genomics, Inc. announced that its highly-accurate whole genome sequencing technology played a pivotal role in identifying a point mutation that causes Prader-Willi Syndrome (PWS). That discovery helped resolve a diagnostic conundrum for four young male patients. These data were published in Nature Genetics. PWS is a rare genetic disorder that causes poor muscle tone, low levels of sex hormones, and a constant feeling of hunger, according to the Eunice Kennedy Shriver National Institute of Child Health and Human Development. As a result, people with this condition tend to overeat, leading to obesity. The first patient in this study was tested for PWS when he was one year old, but the result was negative. Over the next 12 years, he began to manifest some, but not all, of the typical PWS symptoms. Then the patient met with paper author Dr. C. Thomas Caskey, who was director and chief executive officer of the Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, part of the University of Texas Health Science Center at Houston. Dr. Caskey has since joined Baylor College of Medicine as professor of molecular and human genetics. As MAGEL2 is only expressed on the paternal gene, it was important to determine whether the mutation was on the maternal or paternal version of chromosome 15. In this case, the MAGEL2 mutation was confirmed to be on the paternal gene using a modified version of Complete Genomics' Long Fragment Read technology.

Complete Genomics Appoints Ethan Knowlden as Senior Vice President, General Counsel, and Secretary

Complete Genomics, Inc. appointed Ethan Knowlden as senior vice president, general counsel, and secretary. Knowlden joins Complete from Novartis Vaccines and Diagnostics, Inc. where he served as vice president of business development and licensing, and corporate counsel.

Complete Genomics, Inc. Appoints Ethan Knowlden as Senior Vice President, General Counsel, and Secretary

Complete Genomics, Inc. announced that it has appointed Ethan Knowlden as senior vice president, general counsel, and secretary. Knowlden joins Complete from Novartis Vaccines and Diagnostics, Inc. where he served as vice president of business development and licensing, and corporate counsel. Prior to his more than 13 years of corporate experience with Novartis, and its predecessor Chiron Corp., Knowlden spent seven years in private practice.

Similar Private Companies By Industry

Company Name Region
Rho, Inc. United States
inVentiv Health Clinical, Inc. United States
Maxiom Consulting Group, Inc. United States
EDC Biosystems, Inc. United States
Second Genome, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Complete Genomics, Inc., please visit www.completegenomics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.